Literature DB >> 15312407

[The expression and significance of costimulatory molecule in peripheral blood B lymphocytes in rheumatoid arthritis].

Jian-hang Leng1, Zhi-yong Hu, Guang-chao Zhuo, Ke-yi Wang, Zi-wei Wang, Liang Peng, Yu-fang Zhang.   

Abstract

OBJECTIVE: To research the mechanisms of immune function disorder in the patients with rheumatoid arthritis (RA).
METHODS: Monoclonal antibodies against CD(80), CD(86), CD(40) were used for flow cytometry and expression of costimulatory molecule CD(80), CD(86), CD(40) on peripheral blood B lymphocytes was studied in patients with RA, and healthy human were used as control groups. We also used enzyme linked immunosorbent assay to detect the cytokines level of Th1 cell including interleukin (IL)-2, interferon-gamma and those of Th2 cell including IL-6, IL-10. These samples are serum and synovial fluid of patients with RA, respectively.
RESULTS: Compared with control group, the expression of CD(86) on peripheral blood B lymphocytes in patients with RA was obviously decreased (P < 0.01), the expression of CD(40) was also significantly increased (P < 0.05). No statistically significant differences in CD(80) positive peripheral blood B lymphocytes between RA group and control group were observed. Comparing with control group, the level of IL-2 and interferon-gamma in serum and synovial fluid of patients with RA are obviously increase (P < 0.01 or P < 0.05). While, the level of IL-6 and IL-10 are decrease (P < 0.01 or P < 0.05).
CONCLUSIONS: The disorder expression of costimulatory molecule CD(86), CD(40) on peripheral blood B lymphocytes may be associated closely with the imbalance of Th1/Th2 cytokines level in patients with RA. These will give us a new idea on the therapeutic strategy of RA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15312407

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN: 0578-1426


  3 in total

1.  PTPN22 1858C>T polymorphism is associated with increased CD154 expression and higher CD4+ T cells percentage in rheumatoid arthritis patients.

Authors:  Yeniley Ruiz-Noa; Jorge Hernández-Bello; Mara A Llamas-Covarrubias; Claudia A Palafox-Sánchez; Edith Oregon-Romero; Pedro Ernesto Sánchez-Hernández; Maria Guadalupe Ramírez-Dueñas; Isela Parra-Rojas; Jose Francisco Muñoz-Valle
Journal:  J Clin Lab Anal       Date:  2018-11-06       Impact factor: 2.352

2.  Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system.

Authors:  Mikiko Tokunaga; Kazuyoshi Saito; Daisuke Kawabata; Yoshitaka Imura; Takao Fujii; Shingo Nakayamada; Shizuyo Tsujimura; Masao Nawata; Shigeru Iwata; Taeko Azuma; Tsuneyo Mimori; Yoshiya Tanaka
Journal:  Ann Rheum Dis       Date:  2006-11-15       Impact factor: 19.103

3.  Expression of CD80 and CD86 on B cells during coxsackievirus B3-induced acute myocarditis.

Authors:  Yanlan Huang; Bin Wei; Xingcui Gao; Yan Deng; Weifeng Wu
Journal:  Cent Eur J Immunol       Date:  2020-01-20       Impact factor: 2.085

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.